Pernod Ricard reports negative organic net revenue growth (below 0%) for Q1 FY2027 (July–September 2026) — trading update October 15, 2026, confirmed via Pernod Ricard Investor Relations or Bloomberg by October 16, 2026
Pending
✦ AI-generated prediction
Published on 4. October 2026
·
Predicted for 15. October 2026
·
Based on: Historical Cycle
Pernod Ricard publishes its Q1 FY2027 sales update on October 15, 2026 at 7:30am CEST. The company itself explicitly flagged Q1 FY27 as the weakest phase of the season: lingering US inventory destocking and structural China adjustments will weigh on results. Q1 FY26 came in at −7.6% organic (full year FY26: −3.9%). No Polymarket contract for this event; the company's own management guidance, the weak macro environment (US September NFP: +29,000 vs. +90,000 consensus), and the share price near a multi-year low (EUR 59.18) all reflect continued demand weakness in the premium spirits segment. Another quarter of negative organic growth is the base case.
Data basis for this prediction
- Pernod Ricard Q1 FY26: organisch −7,6 %, ausgewiesen −14,3 % (Pernod Ricard IR Pressemitteilung Oktober 2025)
- Pernod Ricard FY26 Jahresergebnis: organisch −3,9 %; Management-Guidance FY27 'broadly stable', Q1 explizit als schwächste Phase bezeichnet (RTTNews / finance.biggo.com, August 2026)
- Pernod Ricard Investor Calendar: Q1 FY2027 Sales Update, 15. Oktober 2026, 07:30 CEST (pernod-ricard.com, Stand 4. Oktober 2026)
- Pernod Ricard Aktienkurs RI.PA: EUR 59,18 nahe Mehrjahrestief; US NFP Miss stärkt Gegenwind-These (ad-hoc-news.de / BLS, Oktober 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
Rémy Cointreau entered FY2026/27 with +1.3% organic growth in Q1 (April–June 2026, €223.2m), led by the Cognac division at +7.7% organic — the strongest quarterly rise in four quarters. Management confirmed mid-2026 a 'return to sustainable organic growth, with momentum expected to strengthen progressively throughout the year.' For H1 organic growth above +2.0%, Q2 (July–September 2026) needs to deliver ~+2.7% organic — plausible given Cognac momentum, favourable base effects (FY2026 full-year −18.0% organic), and typically strong summer trading for premium spirits, but not yet certain. No prediction market or market anchor available; calibrated from Q1 momentum and company guidance.
🍾 Beverages
✦ AI
Analyst consensus is USD 2.57 billion (+3.6% YoY); the threshold of 2.55 billion is 0.8% below that. Constellation Brands has beaten consensus in five of the last six quarters, driven by its beer segment (Corona, Modelo, Pacifico) with sustained US import beer market share. Q2-FY2026 reported USD 2.48 billion; implied growth of ~2.8% is below historical trend. No dedicated Polymarket market; calibrated from historical beat rate (~83%) and adjusted for macro headwinds (weak US consumer per Sept jobs: only 29k vs. 84k forecast). No conflicting open predictions.
🍾 Beverages
✦ AI
Diageo ended FY2026 (through June 2026) with organic net sales down −2.0% (North America −8.4%, driven by tequila −21%; Europe +3.0%). The company issued FY2027 guidance of 'flat' organic net sales growth and announced an ~USD 850m savings programme. Q1 (July–September) benefits seasonally from the summer period and from the gradual normalisation of the US spirits market. A positive Q1 is virtually necessary to support the annual guidance. No specific prediction markets available for this event; Cassandra calibrates at 55%.